Taking people in SwedenNo phase
HPV Testing Versus Cytology for Cervical Screening in Women Aged 23 to 29
Compares HPV testing with cytology screening for cervical cancer in women aged 23 to 29.
Plain-language title generated from the registry record
Registry title: HPV-based Screening Among Women 23-29 Years of Age
Key facts
- Where
- Lund and Stockholm, SwedenSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 23 and 29 years old?
Source: NCT05229679, who can take part
Where in Sweden
- Region of SkåneLund, SwedenNo longer taking part
- Region StockholmStockholm, SwedenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Karolinska Institutet
- Trial code
- NCT05229679
- Record updated
- 19 March 2025
- Original description
The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.Read full original descriptionShow less
Evaluation of Organized Human Papilloma Virus (HPV) Screening of 23-29-year-old Women
The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.
Inclusion: Women ages 23-29 invited to screening.
Exclusion: Women who do not show up for screening or do not consent.